Beneficial Exposome Study of Essential Oils

This study, called the "Beneficial Exposome Study," is looking at how natural compounds might improve your health. Researchers want to understand the positive effects of regular exposure to Hinoki essential oil, Lemon essential oil, or plain water (as a control) diffused nightly for 4 weeks. They will measure your resting heart rate, heart rate variability (how your heart rate changes between beats), and sleep quality over 26 weeks to see if these compounds have a benefit. You can join if you are 18 or older, speak English, live in the US, and do not have certain medical conditions like epilepsy or allergies to the Cupressaceae plant family. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 40 healthy participants. Participants will be assigned to use one of three different diffusers (Hinoki essential oil, Lemon essential oil, or water) each night.
What's involved
Participants will use a diffuser with their assigned compound every night for 4 weeks while they sleep. Measurements of heart rate and sleep quality will be taken at the beginning of the study and again at 26 weeks.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 26 weeks after the start of the study, with final measurements taken at that time.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06093464

Beneficial Exposome Study

Recruiting
NAAges 18+Interventional
Stanford University
~40 participants
Updated 2024-12-04 on ClinicalTrials.gov
What's tested:Natural Compound A (Hinoki essential oil)Natural Compound B (Lemon essential oil)Natural Compound C (Control/Water)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Resting Heart Rate
Measured over Baseline; 26 weeks
+3 more outcomes measured
Healthy
1 sites across 1 states
California1
  • Michael Snyder, PhD · PRINCIPAL_INVESTIGATOR · Stanford University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years of age and older
Read, speak, and understand English
Live in the US territory

Exclusion

Mental incapacity and/or cognitive impairment on the part of the patient that would preclude adequate understanding of, or cooperation with, the study protocol
Is pregnant
Is breastfeeding
Has epilepsy
Has allergies to Cupressaceae family of plants, common plants include redwoods, junipers, cypress, cedar, fir, and sequoia
  • Resting Heart RateBaseline; 26 weeks

    Change in resting heart rate measured by wearable devices

  • Heart Rate VariabilityBaseline; 26 weeks

    Change in resting heart rate measured by wearable devices

  • Change in sleep quality measured as duration of sleep stagesBaseline; 26 weeks

    Duration of each sleep stage \[i.e. light, deep, rapid eye movement (REM), wake stages\] overnight. Sleep quality will be measured via a wearable device. Sleep quality will be compared to baseline through the other intervention phases.

  • Profile of Mood StatesBaseline; weeks 2, 6, 10, 14, 18, 22, and 26

    Change in mood states, a 65 item scale that allow for the quick assessment of transient, fluctuating feelings and enduring affect states.